Kodak Sued Over Execs' Stock Trading Linked To $765M Loan
Eastman Kodak Co. is facing a proposed securities class action one week after the government paused its $765 million COVID-19 drug development loan to the company over "recent allegations of wrongdoing"...To view the full article, register now.
Already a subscriber? Click here to view full article